Brain-infecting fungus that can kill 7 in 10 patients is on the rise across America - Fox News
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
NEWYou can now listen to Fox News articles!
A rare fungal infection that can strike healthy people is rising across the U. S., prompting calls from public health officials for heightened awareness and national tracking. Cladophialophora bantiana (C. bantiana) is a black yeast-like mold that can infect the brain and contains a dark pigment called melanin, according to a new report from the Centers for Disease Control and Prevention. Data from a microbiology laboratory at the University of Washington shows that detection of the fungus nearly quadrupled between 2023 and 2025. LOUISIANA GIRL, 8, DIES AFTER CONTRACTING SUSPECTED BRAIN-EATING AMOEBA LINKED TO LAKE SWIMBetween January 2009 and July 2026, researchers identified 48 confirmed cases and one probable case of C. bantiana in tissue samples from 21 states and the District of Columbia. The median patient age was 68 years old. Unlike many fungal infections that mainly affect people with weakened immune systems, about half of C. bantiana infections occur in otherwise healthy people. Cladophialophora bantiana (C.
This article is an excerpt. To read the full content, visit the original source. Fox News
Related articles
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!